During the past decade, Swedish Sleep Medicine Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Swedish Sleep Medicine Institute" are "Narcolepsy" (2 trials), "Chronic Shift Work Sleep Disorder" (1 trials), "Excessive Daytime Sleepiness" (1 trials) and "Obstructive Sleep Apnea/Hypopnea Syndrome" (1 trials). Many other conditions were trialed in "Swedish Sleep Medicine Institute" in a lesser frequency.

Most popular intervention types in "Swedish Sleep Medicine Institute" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Armodafinil 100 to 250 mg/day" (1 trials) and "sodium oxybate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Swedish Sleep Medicine Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Swedish Sleep Medicine Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Swedish Sleep Medicine Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Swedish Sleep Medicine Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".